[hlHome]

0

Back to AJCP CME: Magee Equation 3 demonstrates predictive and prognostic value for neoadjuvant chemotherapy outcomes in estrogen receptor–positive, human epidermal growth factor receptor 2–negative breast cancer
AJCP CME: Magee Equation 3 demonstrates predictive and prognostic value for neoadjuvant chemotherapy outcomes in estrogen receptor–positive, human epidermal growth factor receptor 2–negative breast cancer

AJCP CME: Magee Equation 3 demonstrates predictive and prognostic value for neoadjuvant chemotherapy outcomes in estrogen receptor–positive, human epidermal growth factor receptor 2–negative breast cancer

 

This AJCP article offers 1.0 continuing education (CME) credit that can be used to fulfill CC Part II requirements. Purchase of this CME activity provides gratis access to a PDF of the journal article for the learner’s personal use only.

  • List Price: $25.00
  • Member Price: $19.00
 
Want to save more?
Log into see if you qualify for a lower rate.
Members save $6.00 or more Join
Item Details:

Intended Audience: Pathologists, Pathology Residents, Pathologist Assistants, Research Scientists 


Upon completion of this activity, learners will be able to:

  • Summarize ways the The Magee Equations can be widely used and cost-effective in the pathological evaluation of breast carcinoma...
Back to AJCP CME: Magee Equation 3 demonstrates predictive and prognostic value for neoadjuvant chemotherapy outcomes in estrogen receptor–positive, human epidermal growth factor receptor 2–negative breast cancer
View More View Less

Bought This Bought That ...